Interventional Cardiology Devices Market worth $21.2 billion by 2025
According to the new market research report "Interventional Cardiology Devices Market
by type (Stents, Structural Heart, Catheters, Plaque Modification
(Atherectomy), Hemodynamic Flow Alteration (Embolic Protection, Total
Occlusion), Guidewire, Introducer Sheath, IVUS)) - Global Forecast to
2025", published by MarketsandMarkets™, the global Interventional
Cardiology Devices Market size is projected to reach USD 21.2 billion by
2025 from USD 13.8 billion in 2020, at a CAGR of 8.9%.
Browse in-depth TOC on "Interventional Cardiology Devices Market"
179 – Tables
38 – Figures
196 – Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=548
The
Growth in this market is driven mainly by the rapid growth in the
geriatric population and the associated increase in the prevalence of
coronary artery diseases, approval of new and advanced products, and the
growing preference for minimally invasive surgeries.
The old/normal balloons segment accounted for the largest share of the angioplasty balloons market in 2019.
Based
on type, the angioplasty balloons market is segmented into old/normal
balloons, cutting and scoring balloons, and drug-eluting balloons. In
2019, the old/normal balloons segment accounted for the largest share of
the angioplasty balloons market. The large share of this segment can be
attributed to a increasing its use in impating the stents and
structural heart devices; and increasing prevalence of vaulvuloplasty.
Thrombectomy devices segment accounted for the largest share of the plaque modification devices market in 2019.
Based
on type, the plaque modification devices market is segmented into
atherectomy devices and thrombectomy devices. In 2019, the thrombectomy
devices segment accounted for the largest share of the plaque
modification devices market. Growth in this market segment can largely
be attributed to the increasing incidence of blood clots and atrial
embolisms across the globe.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=548
North America accounted for the largest share of the interventional cardiology devices market in 2019.
North
America accounted for the largest share of the interventional
cardiology market in 2019. The large share of this segment can primarily
be attributed to the rising incidence of cardiovascular diseases, the
growing geriatric population, and the strong presence of industry
players in the region.
Some of the major players in the
interventional cardiology devices market include Medtronic (US), Boston
Scientific Corporation (US), Abbott (US), Cardinal Health (US),
iVascular (Spain), Edward Lifescinces Corporation (US), B. Braun
Melsungen (Germany), Terumo Corporation (Japan), Biosensors
International Group (Singapore), and BIOTRONIK SE & Co. KG
(Germany).
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Comments
Post a Comment